25 XP   0   0   10

Aeterna Zentaris Inc
Buy, Hold or Sell?

Let's analyse Zentaris together

PenkeI guess you are interested in Aeterna Zentaris Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Aeterna Zentaris Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Aeterna Zentaris Inc

I send you an email if I find something interesting about Aeterna Zentaris Inc.

Quick analysis of Zentaris (30 sec.)










What can you expect buying and holding a share of Zentaris? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$5.13
Expected worth in 1 year
C$0.19
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
C$-4.94
Return On Investment
-185.8%

For what price can you sell your share?

Current Price per Share
C$2.66
Expected price per share
C$2.28 - C$3.01
How sure are you?
50%

1. Valuation of Zentaris (5 min.)




Live pricePrice per Share (EOD)

C$2.66

Intrinsic Value Per Share

C$-138.88 - C$-74.28

Total Value Per Share

C$-133.74 - C$-69.14

2. Growth of Zentaris (5 min.)




Is Zentaris growing?

Current yearPrevious yearGrowGrow %
How rich?$18.1m$48.1m-$21.9m-83.9%

How much money is Zentaris making?

Current yearPrevious yearGrowGrow %
Making money-$4.1m-$7.5m$3.3m81.3%
Net Profit Margin-35,785.2%125.6%--

How much money comes from the company's main activities?

3. Financial Health of Zentaris (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#596 / 1009

Most Revenue
#491 / 1009

Most Profit
#397 / 1009

Most Efficient
#978 / 1009

What can you expect buying and holding a share of Zentaris? (5 min.)

Welcome investor! Zentaris's management wants to use your money to grow the business. In return you get a share of Zentaris.

What can you expect buying and holding a share of Zentaris?

First you should know what it really means to hold a share of Zentaris. And how you can make/lose money.

Speculation

The Price per Share of Zentaris is C$2.66. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zentaris.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zentaris, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$5.13. Based on the TTM, the Book Value Change Per Share is C$-1.24 per quarter. Based on the YOY, the Book Value Change Per Share is C$-1.22 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zentaris.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps-1.16-43.6%-0.85-32.0%-1.17-44.0%-0.61-22.8%-0.84-31.6%
Usd Book Value Change Per Share-1.66-62.6%-0.90-33.9%-0.89-33.4%0.176.3%0.010.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.66-62.6%-0.90-33.9%-0.89-33.4%0.176.3%0.010.2%
Usd Price Per Share1.88-2.31-1.88-1.55-1.71-
Price to Earnings Ratio-0.40--0.75--0.47-0.17--0.24-
Price-to-Total Gains Ratio-1.13--3.40-1.32--0.31--1.52-
Price to Book Ratio0.50-0.44-0.21--0.29-0.32-
Price-to-Total Gains Ratio-1.13--3.40-1.32--0.31--1.52-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.942066
Number of shares514
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.900.17
Usd Total Gains Per Share-0.900.17
Gains per Quarter (514 shares)-463.7486.22
Gains per Year (514 shares)-1,854.96344.87
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1855-18650345335
20-3710-37200690680
30-5565-5575010351025
40-7420-7430013791370
50-9275-9285017241715
60-11130-11140020692060
70-12985-12995024142405
80-14840-14850027592750
90-16695-16705031043095
100-18550-18560034493440

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%2.018.00.010.0%4.036.00.010.0%20.086.02.018.5%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%7.013.00.035.0%13.027.00.032.5%47.061.00.043.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.0108.00.0%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%7.013.00.035.0%13.027.00.032.5%47.061.00.043.5%

Fundamentals of Zentaris

About Aeterna Zentaris Inc

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is Macrilen (macimorelin), an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications; and AEZS-150, a delayed clearance parathyroid hormonefusion polypeptide that is in preclinical trail for the treatment of hypoparathyroidism in adults. Aeterna Zentaris Inc. has a license agreement with University of Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercialization of the treatment for neuromyelitis optica spectrum disorder; and for pre-clinical development towards the potential treatment of Parkinson's disease. It also has a license agreement with Consilient Health Ltd. and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the Republic of Korea; a distribution and commercialization agreement with Er-Kim Pharmaceuticals Bulgaria EOOD for the commercialization of macimorelin for the diagnosis of growth hormone deficiency in children and adults in Turkey and some non-European Union Balkan countries; as well as The University of Sheffield, the United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.

Fundamental data was last updated by Penke on 2024-04-10 23:48:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Aeterna Zentaris Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zentaris earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Zentaris to the Biotechnology industry mean.
  • A Net Profit Margin of -4,657.0% means that $-46.57 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Aeterna Zentaris Inc:

  • The MRQ is -4,657.0%. The company is making a huge loss. -2
  • The TTM is -35,785.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-4,657.0%TTM-35,785.2%+31,128.2%
TTM-35,785.2%YOY125.6%-35,910.8%
TTM-35,785.2%5Y-8,420.8%-27,364.4%
5Y-8,420.8%10Y-4,830.9%-3,590.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4,657.0%-200.1%-4,456.9%
TTM-35,785.2%-216.8%-35,568.4%
YOY125.6%-288.3%+413.9%
5Y-8,420.8%-449.1%-7,971.7%
10Y-4,830.9%-605.5%-4,225.4%
1.1.2. Return on Assets

Shows how efficient Zentaris is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zentaris to the Biotechnology industry mean.
  • -15.2% Return on Assets means that Zentaris generated $-0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Aeterna Zentaris Inc:

  • The MRQ is -15.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.2%TTM-9.7%-5.5%
TTM-9.7%YOY-12.6%+2.9%
TTM-9.7%5Y-7.5%-2.2%
5Y-7.5%10Y-10.2%+2.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.2%-13.3%-1.9%
TTM-9.7%-12.8%+3.1%
YOY-12.6%-11.7%-0.9%
5Y-7.5%-13.9%+6.4%
10Y-10.2%-15.7%+5.5%
1.1.3. Return on Equity

Shows how efficient Zentaris is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zentaris to the Biotechnology industry mean.
  • -31.0% Return on Equity means Zentaris generated $-0.31 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Aeterna Zentaris Inc:

  • The MRQ is -31.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -17.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-31.0%TTM-17.3%-13.6%
TTM-17.3%YOY-19.1%+1.7%
TTM-17.3%5Y-25.1%+7.7%
5Y-25.1%10Y-45.8%+20.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-31.0%-16.9%-14.1%
TTM-17.3%-16.1%-1.2%
YOY-19.1%-15.1%-4.0%
5Y-25.1%-19.3%-5.8%
10Y-45.8%-20.2%-25.6%

1.2. Operating Efficiency of Aeterna Zentaris Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zentaris is operating .

  • Measures how much profit Zentaris makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zentaris to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Aeterna Zentaris Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-81.2%+81.2%
TTM-81.2%YOY394.4%-475.6%
TTM-81.2%5Y-1,252.8%+1,171.5%
5Y-1,252.8%10Y-1,041.6%-211.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM-81.2%-232.5%+151.3%
YOY394.4%-298.2%+692.6%
5Y-1,252.8%-492.1%-760.7%
10Y-1,041.6%-632.4%-409.2%
1.2.2. Operating Ratio

Measures how efficient Zentaris is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 54.31 means that the operating costs are $54.31 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Aeterna Zentaris Inc:

  • The MRQ is 54.314. The company is inefficient in keeping operating costs low. -1
  • The TTM is 395.239. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ54.314TTM395.239-340.925
TTM395.239YOY-2.944+398.184
TTM395.2395Y92.123+303.116
5Y92.12310Y86.224+5.899
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ54.3143.231+51.083
TTM395.2393.310+391.929
YOY-2.9443.890-6.834
5Y92.1235.739+86.384
10Y86.2247.876+78.348

1.3. Liquidity of Aeterna Zentaris Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zentaris is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 8.01 means the company has $8.01 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Aeterna Zentaris Inc:

  • The MRQ is 8.010. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.265. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.010TTM9.265-1.255
TTM9.265YOY9.850-0.585
TTM9.2655Y8.338+0.927
5Y8.33810Y6.692+1.646
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.0103.890+4.120
TTM9.2654.173+5.092
YOY9.8505.344+4.506
5Y8.3386.126+2.212
10Y6.6926.448+0.244
1.3.2. Quick Ratio

Measures if Zentaris is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zentaris to the Biotechnology industry mean.
  • A Quick Ratio of 0.01 means the company can pay off $0.01 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Aeterna Zentaris Inc:

  • The MRQ is 0.015. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 6.861. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.015TTM6.861-6.847
TTM6.861YOY9.475-2.614
TTM6.8615Y7.527-0.665
5Y7.52710Y6.208+1.319
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0153.514-3.499
TTM6.8613.998+2.863
YOY9.4755.380+4.095
5Y7.5276.105+1.422
10Y6.2086.404-0.196

1.4. Solvency of Aeterna Zentaris Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zentaris assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zentaris to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.51 means that Zentaris assets are financed with 50.8% credit (debt) and the remaining percentage (100% - 50.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Aeterna Zentaris Inc:

  • The MRQ is 0.508. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.414. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.508TTM0.414+0.094
TTM0.414YOY0.292+0.122
TTM0.4145Y0.577-0.163
5Y0.57710Y0.686-0.110
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5080.339+0.169
TTM0.4140.336+0.078
YOY0.2920.271+0.021
5Y0.5770.366+0.211
10Y0.6860.389+0.297
1.4.2. Debt to Equity Ratio

Measures if Zentaris is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zentaris to the Biotechnology industry mean.
  • A Debt to Equity ratio of 103.4% means that company has $1.03 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Aeterna Zentaris Inc:

  • The MRQ is 1.034. The company is able to pay all its debts with equity. +1
  • The TTM is 0.723. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.034TTM0.723+0.311
TTM0.723YOY0.418+0.305
TTM0.7235Y1.888-1.164
5Y1.88810Y2.769-0.881
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0340.388+0.646
TTM0.7230.402+0.321
YOY0.4180.335+0.083
5Y1.8880.426+1.462
10Y2.7690.461+2.308

2. Market Valuation of Aeterna Zentaris Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Zentaris generates.

  • Above 15 is considered overpriced but always compare Zentaris to the Biotechnology industry mean.
  • A PE ratio of -0.40 means the investor is paying $-0.40 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Aeterna Zentaris Inc:

  • The EOD is -0.418. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.404. Based on the earnings, the company is expensive. -2
  • The TTM is -0.749. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.418MRQ-0.404-0.014
MRQ-0.404TTM-0.749+0.345
TTM-0.749YOY-0.472-0.277
TTM-0.7495Y0.172-0.922
5Y0.17210Y-0.241+0.414
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.418-2.264+1.846
MRQ-0.404-2.629+2.225
TTM-0.749-2.680+1.931
YOY-0.472-4.145+3.673
5Y0.172-6.257+6.429
10Y-0.241-6.254+6.013
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Aeterna Zentaris Inc:

  • The EOD is -0.438. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.423. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.681. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.438MRQ-0.423-0.015
MRQ-0.423TTM-0.681+0.258
TTM-0.681YOY-0.661-0.020
TTM-0.6815Y-0.607-0.074
5Y-0.60710Y-0.498-0.108
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.438-2.973+2.535
MRQ-0.423-3.333+2.910
TTM-0.681-3.553+2.872
YOY-0.661-5.605+4.944
5Y-0.607-8.376+7.769
10Y-0.498-8.865+8.367
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zentaris is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.50 means the investor is paying $0.50 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Aeterna Zentaris Inc:

  • The EOD is 0.518. Based on the equity, the company is cheap. +2
  • The MRQ is 0.501. Based on the equity, the company is cheap. +2
  • The TTM is 0.436. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.518MRQ0.501+0.018
MRQ0.501TTM0.436+0.065
TTM0.436YOY0.214+0.222
TTM0.4365Y-0.292+0.728
5Y-0.29210Y0.316-0.608
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.5181.896-1.378
MRQ0.5012.115-1.614
TTM0.4362.093-1.657
YOY0.2142.884-2.670
5Y-0.2923.542-3.834
10Y0.3163.916-3.600
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Aeterna Zentaris Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---2.280-1.236-46%-1.218-47%0.230-1092%0.008-28658%
Book Value Per Share--5.1337.388-31%13.582-62%7.835-34%5.209-1%
Current Ratio--8.0109.265-14%9.850-19%8.338-4%6.692+20%
Debt To Asset Ratio--0.5080.414+23%0.292+74%0.577-12%0.686-26%
Debt To Equity Ratio--1.0340.723+43%0.418+147%1.888-45%2.769-63%
Dividend Per Share----0%-0%-0%-0%
Eps---1.590-1.167-27%-1.601+1%-0.829-48%-1.150-28%
Free Cash Flow Per Share---1.519-1.209-20%-0.965-36%-0.774-49%-1.165-23%
Free Cash Flow To Equity Per Share---1.530-1.225-20%-0.973-36%0.284-638%-0.053-97%
Gross Profit Margin--1.0001.0000%1.092-8%1.009-1%1.125-11%
Intrinsic Value_10Y_max---74.276--------
Intrinsic Value_10Y_min---138.875--------
Intrinsic Value_1Y_max---4.304--------
Intrinsic Value_1Y_min---6.271--------
Intrinsic Value_3Y_max---15.323--------
Intrinsic Value_3Y_min---25.576--------
Intrinsic Value_5Y_max---29.227--------
Intrinsic Value_5Y_min---52.112--------
Market Cap12916640.800+3%12479611.60015332441.100-19%12536546.8000%10293712.940+21%11406085.790+9%
Net Profit Margin---46.570-357.852+668%1.256-3807%-84.208+81%-48.309+4%
Operating Margin----0.8120%3.944-100%-12.5280%-10.4160%
Operating Ratio--54.314395.239-86%-2.944+105%92.123-41%86.224-37%
Pb Ratio0.518+3%0.5010.436+15%0.214+134%-0.292+158%0.316+58%
Pe Ratio-0.418-4%-0.404-0.749+85%-0.472+17%0.172-335%-0.241-40%
Price Per Share2.660+3%2.5703.158-19%2.5800%2.120+21%2.349+9%
Price To Free Cash Flow Ratio-0.438-4%-0.423-0.681+61%-0.661+56%-0.607+43%-0.498+18%
Price To Total Gains Ratio-1.167-4%-1.127-3.395+201%1.318-186%-0.306-73%-1.521+35%
Quick Ratio--0.0156.861-100%9.475-100%7.527-100%6.208-100%
Return On Assets---0.152-0.097-36%-0.126-17%-0.075-51%-0.102-33%
Return On Equity---0.310-0.173-44%-0.191-38%-0.251-19%-0.458+48%
Total Gains Per Share---2.280-1.236-46%-1.218-47%0.230-1092%0.008-28658%
Usd Book Value--18197655.47226192632.789-31%48166131.756-62%27781227.306-34%18468705.130-1%
Usd Book Value Change Per Share---1.665-0.902-46%-0.889-47%0.168-1092%0.006-28658%
Usd Book Value Per Share--3.7485.394-31%9.916-62%5.721-34%3.803-1%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.161-0.852-27%-1.169+1%-0.606-48%-0.840-28%
Usd Free Cash Flow---5385489.927-4284639.781-20%-3423061.402-36%-2745349.749-49%-4129300.650-23%
Usd Free Cash Flow Per Share---1.109-0.882-20%-0.705-36%-0.565-49%-0.850-23%
Usd Free Cash Flow To Equity Per Share---1.117-0.894-20%-0.711-36%0.208-638%-0.038-97%
Usd Market Cap9430439.448+3%9111364.42911194215.247-19%9152932.8190%7515439.817+21%8327583.235+9%
Usd Price Per Share1.942+3%1.8762.305-19%1.8840%1.547+21%1.715+9%
Usd Profit---5635512.672-4165378.932-26%-7550936.922+34%-3319752.004-41%-4266988.175-24%
Usd Revenue--121011.0091124602.307-89%1410128.282-91%979189.079-88%1221436.116-90%
Usd Total Gains Per Share---1.665-0.902-46%-0.889-47%0.168-1092%0.006-28658%
 EOD+5 -3MRQTTM+4 -28YOY+4 -305Y+8 -2510Y+11 -22

3.2. Fundamental Score

Let's check the fundamental score of Aeterna Zentaris Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.418
Price to Book Ratio (EOD)Between0-10.518
Net Profit Margin (MRQ)Greater than0-46.570
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.015
Current Ratio (MRQ)Greater than18.010
Debt to Asset Ratio (MRQ)Less than10.508
Debt to Equity Ratio (MRQ)Less than11.034
Return on Equity (MRQ)Greater than0.15-0.310
Return on Assets (MRQ)Greater than0.05-0.152
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Aeterna Zentaris Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.550
Ma 20Greater thanMa 502.782
Ma 50Greater thanMa 1002.653
Ma 100Greater thanMa 2002.667
OpenGreater thanClose2.680
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets37,016
Total Liabilities18,820
Total Stockholder Equity18,196
 As reported
Total Liabilities 18,820
Total Stockholder Equity+ 18,196
Total Assets = 37,016

Assets

Total Assets37,016
Total Current Assets36,367
Long-term Assets649
Total Current Assets
Cash And Cash Equivalents 34,016
Net Receivables 67
Inventory 66
Other Current Assets 59
Total Current Assets  (as reported)36,367
Total Current Assets  (calculated)34,208
+/- 2,159
Long-term Assets
Property Plant Equipment 317
Long-term Assets Other 332
Long-term Assets  (as reported)649
Long-term Assets  (calculated)649
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities4,540
Long-term Liabilities14,280
Total Stockholder Equity18,196
Total Current Liabilities
Accounts payable 1,866
Total Current Liabilities  (as reported)4,540
Total Current Liabilities  (calculated)1,866
+/- 2,674
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt279
Long-term Liabilities  (as reported)14,280
Long-term Liabilities  (calculated)279
+/- 14,001
Total Stockholder Equity
Total Stockholder Equity (as reported)18,196
Total Stockholder Equity (calculated)0
+/- 18,196
Other
Capital Stock293,410
Common Stock Shares Outstanding 4,856
Net Invested Capital 18,196
Net Working Capital 31,827
Property Plant and Equipment Gross 1,481



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-31
> Total Assets 
27,538
35,275
35,616
34,172
34,026
32,605
32,231
31,195
31,279
31,543
30,643
41,998
51,143
58,007
63,797
64,184
61,396
60,512
81,076
84,393
82,128
121,228
115,301
210,230
180,084
185,066
225,126
228,089
261,470
274,548
284,202
290,506
320,973
305,645
298,935
425,538
424,185
436,111
432,063
223,491
139,276
135,266
133,749
123,363
117,454
95,549
72,558
108,342
119,031
117,440
103,616
86,262
71,972
85,516
80,860
76,574
68,993
79,228
74,764
75,369
74,053
65,368
58,268
67,665
59,394
52,911
49,971
59,196
61,648
54,140
55,517
47,435
65,274
57,246
48,901
51,498
44,046
37,067
31,739
31,659
28,081
24,506
22,538
22,195
36,441
31,634
28,462
25,011
22,384
20,751
21,502
19,981
19,641
17,669
32,271
37,277
87,014
84,352
82,042
80,102
76,344
71,825
66,606
56,026
51,282
46,483
42,486
37,016
37,01642,48646,48351,28256,02666,60671,82576,34480,10282,04284,35287,01437,27732,27117,66919,64119,98121,50220,75122,38425,01128,46231,63436,44122,19522,53824,50628,08131,65931,73937,06744,04651,49848,90157,24665,27447,43555,51754,14061,64859,19649,97152,91159,39467,66558,26865,36874,05375,36974,76479,22868,99376,57480,86085,51671,97286,262103,616117,440119,031108,34272,55895,549117,454123,363133,749135,266139,276223,491432,063436,111424,185425,538298,935305,645320,973290,506284,202274,548261,470228,089225,126185,066180,084210,230115,301121,22882,12884,39381,07660,51261,39664,18463,79758,00751,14341,99830,64331,54331,27931,19532,23132,60534,02634,17235,61635,27527,538
   > Total Current Assets 
26,596
34,188
34,530
32,565
32,124
30,427
28,824
24,501
21,538
20,350
19,407
30,594
39,826
46,974
52,988
51,788
47,064
48,315
56,838
55,491
53,117
88,637
83,671
112,070
76,304
78,993
107,737
103,831
106,027
115,080
118,883
120,397
140,076
130,884
123,944
161,703
159,350
158,396
157,541
101,723
75,836
71,565
67,075
59,580
57,208
42,845
26,331
61,724
73,479
70,755
54,740
49,013
37,330
54,636
47,258
44,175
50,343
60,939
58,548
60,139
58,578
50,832
43,798
53,301
45,632
39,450
36,264
45,655
48,342
41,524
44,076
36,217
55,551
47,400
39,551
42,394
34,339
27,540
21,956
22,743
18,962
14,938
12,975
9,381
26,860
22,710
19,553
16,256
13,403
11,769
12,793
10,910
11,047
9,055
23,316
27,886
77,556
74,728
72,400
70,820
67,097
63,173
58,610
55,488
50,708
45,893
41,911
36,367
36,36741,91145,89350,70855,48858,61063,17367,09770,82072,40074,72877,55627,88623,3169,05511,04710,91012,79311,76913,40316,25619,55322,71026,8609,38112,97514,93818,96222,74321,95627,54034,33942,39439,55147,40055,55136,21744,07641,52448,34245,65536,26439,45045,63253,30143,79850,83258,57860,13958,54860,93950,34344,17547,25854,63637,33049,01354,74070,75573,47961,72426,33142,84557,20859,58067,07571,56575,836101,723157,541158,396159,350161,703123,944130,884140,076120,397118,883115,080106,027103,831107,73778,99376,304112,07083,67188,63753,11755,49156,83848,31547,06451,78852,98846,97439,82630,59419,40720,35021,53824,50128,82430,42732,12432,56534,53034,18826,596
       Cash And Cash Equivalents 
22,973
30,784
30,476
27,952
27,263
25,798
24,632
20,667
17,495
15,602
16,343
4,160
11,346
22,229
17,309
4,842
5,465
16,326
16,934
7,534
6,252
24,790
17,201
7,936
26,405
22,665
45,011
17,284
14,902
25,360
20,968
23,735
23,626
22,252
17,872
27,267
25,126
27,926
27,650
9,356
6,724
9,069
5,671
10,272
16,848
11,435
7,348
49,226
61,994
56,817
43,051
38,100
26,947
45,311
39,866
31,998
38,317
46,612
48,114
46,881
45,583
39,759
33,202
39,521
33,183
25,339
24,829
43,202
45,752
39,553
41,952
34,931
53,259
45,458
38,345
41,450
32,981
26,169
21,052
21,999
17,777
13,931
12,173
7,780
24,548
19,946
16,800
14,512
11,357
9,683
10,862
7,838
9,182
6,743
21,746
24,271
73,371
69,868
68,002
65,300
63,596
58,157
53,816
50,611
46,560
42,186
38,756
34,016
34,01638,75642,18646,56050,61153,81658,15763,59665,30068,00269,86873,37124,27121,7466,7439,1827,83810,8629,68311,35714,51216,80019,94624,5487,78012,17313,93117,77721,99921,05226,16932,98141,45038,34545,45853,25934,93141,95239,55345,75243,20224,82925,33933,18339,52133,20239,75945,58346,88148,11446,61238,31731,99839,86645,31126,94738,10043,05156,81761,99449,2267,34811,43516,84810,2725,6719,0696,7249,35627,65027,92625,12627,26717,87222,25223,62623,73520,96825,36014,90217,28445,01122,66526,4057,93617,20124,7906,2527,53416,93416,3265,4654,84217,30922,22911,3464,16016,34315,60217,49520,66724,63225,79827,26327,95230,47630,78422,973
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
18,837
30,168
40,939
34,010
23,626
20,005
26,427
21,350
35,986
38,682
43,854
9,281
13,828
10,727
32,352
24,748
22,940
28,984
24,587
31,354
29,957
30,019
25,438
21,866
19,167
18,148
51,663
48,713
42,344
42,020
31,115
21,843
13,392
3,609
493
477
518
562
0
0
0
0
1,934
2,770
3,029
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000003,0292,7701,93400005625184774933,60913,39221,84331,11542,02042,34448,71351,66318,14819,16721,86625,43830,01929,95731,35424,58728,98422,94024,74832,35210,72713,8289,28143,85438,68235,98621,35026,42720,00523,62634,01040,93930,16818,8370000000000000
       Net Receivables 
2,174
2,173
2,968
3,704
3,522
3,403
3,079
2,860
3,247
3,663
2,179
2,438
3,304
3,593
3,399
3,230
4,370
4,511
14,148
14,675
19,084
19,822
19,205
47,538
27,641
28,917
35,822
37,163
44,786
44,738
45,136
48,487
57,852
51,809
48,877
65,231
71,093
63,362
68,474
9,772
9,456
10,824
10,561
9,214
9,244
10,108
8,855
4,525
1,497
3,940
2,851
3,436
4,502
4,336
1,236
5,421
4,089
4,404
5,461
8,325
7,099
4,609
4,585
7,993
6,672
8,186
7,160
1,953
1,760
1,367
1,615
867
1,562
1,450
951
598
464
641
384
365
240
245
283
221
304
1,367
574
294
612
494
1,349
658
665
814
841
1,681
1,075
1,493
910
3,675
2,173
2,296
2,082
2,160
2,007
977
546
67
675469772,0072,1602,0822,2962,1733,6759101,4931,0751,6818418146656581,3494946122945741,3673042212832452403653846414645989511,4501,5628671,6151,3671,7601,9537,1608,1866,6727,9934,5854,6097,0998,3255,4614,4044,0895,4211,2364,3364,5023,4362,8513,9401,4974,5258,85510,1089,2449,21410,56110,8249,4569,77268,47463,36271,09365,23148,87751,80957,85248,48745,13644,73844,78637,16335,82228,91727,64147,53819,20519,82219,08414,67514,1484,5114,3703,2303,3993,5933,3042,4382,1793,6633,2472,8603,0793,4033,5223,7042,9682,1732,174
       Inventory 
652
869
796
839
1,057
1,021
852
910
663
882
749
807
1,077
1,005
1,170
1,657
1,620
1,835
3,639
5,216
4,345
5,354
6,234
10,376
10,646
11,301
14,241
12,469
16,006
16,177
17,955
17,787
21,041
21,337
22,247
37,258
33,975
36,467
35,813
5,367
5,189
4,936
5,960
5,406
5,482
4,918
4,169
3,385
3,670
3,587
3,391
4,415
3,491
3,759
4,052
3,311
3,875
4,884
4,180
3,456
3,715
4,855
4,254
4,084
3,141
3,590
2,986
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
643
1,096
1,397
1,608
240
540
562
582
1,203
367
375
371
21
60
59
57
73
278
261
238
229
227
93
91
66
66919322722923826127873575960213713753671,2035825625402401,6081,3971,09664300000000000000002,9863,5903,1414,0844,2544,8553,7153,4564,1804,8843,8753,3114,0523,7593,4914,4153,3913,5873,6703,3854,1694,9185,4825,4065,9604,9365,1895,36735,81336,46733,97537,25822,24721,33721,04117,78717,95516,17716,00612,46914,24111,30110,64610,3766,2345,3544,3455,2163,6391,8351,6201,6571,1701,0051,0778077498826639108521,0211,057839796869652
       Other Current Assets 
797
362
290
70
282
204
262
65
133
204
136
23,189
24,099
1,310
942
1,121
1,598
2,018
2,111
1,640
2,087
2,685
2,350
2,365
2,330
2,281
1,937
4,564
5,585
5,865
5,841
5,801
6,203
5,530
4,929
6,509
7,290
11,474
7,456
25,565
5,753
4,393
2,864
3,573
3,791
2,992
2,350
4,095
5,841
5,893
4,885
3,062
2,390
1,230
2,104
1,511
1,292
2,010
793
1,477
2,181
1,609
1,757
1,703
2,636
2,335
1,289
500
830
604
509
419
730
492
255
346
894
730
520
379
945
762
519
737
912
0
571
1,210
894
1,030
0
1,211
833
1,123
358
1,913
3,050
3,308
3,431
1,772
143
2,459
74
2,488
1,914
2,637
2,402
59
592,4022,6371,9142,488742,4591431,7723,4313,3083,0501,9133581,1238331,21101,0308941,21057109127375197629453795207308943462554927304195096048305001,2892,3352,6361,7031,7571,6092,1811,4777932,0101,2921,5112,1041,2302,3903,0624,8855,8935,8414,0952,3502,9923,7913,5732,8644,3935,75325,5657,45611,4747,2906,5094,9295,5306,2035,8015,8415,8655,5854,5641,9372,2812,3302,3652,3502,6852,0871,6402,1112,0181,5981,1219421,31024,09923,1891362041336526220428270290362797
   > Long-term Assets 
942
1,086
1,086
1,607
1,902
2,178
3,406
6,694
9,742
11,193
11,236
11,404
11,317
11,034
10,810
12,396
14,332
12,197
24,238
28,902
29,011
32,591
31,630
98,161
103,780
106,073
117,388
124,258
155,444
159,468
165,319
170,109
180,897
174,762
174,991
263,835
264,835
277,715
274,521
121,768
63,441
63,701
66,674
63,783
60,246
52,704
46,227
46,618
45,552
46,685
48,876
37,249
34,642
30,880
33,602
32,399
18,650
18,289
16,216
15,230
15,475
14,536
14,470
14,364
13,762
13,461
13,707
13,541
13,306
12,616
11,441
11,218
9,723
9,846
9,350
9,104
9,707
9,527
9,783
8,916
9,119
9,568
9,563
12,814
9,581
8,924
8,909
8,755
8,981
8,982
8,709
9,071
8,594
8,614
8,955
9,391
9,458
9,624
9,642
9,282
9,247
8,652
7,996
538
574
590
575
649
6495755905745387,9968,6529,2479,2829,6429,6249,4589,3918,9558,6148,5949,0718,7098,9828,9818,7558,9098,9249,58112,8149,5639,5689,1198,9169,7839,5279,7079,1049,3509,8469,72311,21811,44112,61613,30613,54113,70713,46113,76214,36414,47014,53615,47515,23016,21618,28918,65032,39933,60230,88034,64237,24948,87646,68545,55246,61846,22752,70460,24663,78366,67463,70163,441121,768274,521277,715264,835263,835174,991174,762180,897170,109165,319159,468155,444124,258117,388106,073103,78098,16131,63032,59129,01128,90224,23812,19714,33212,39610,81011,03411,31711,40411,23611,1939,7426,6943,4062,1781,9021,6071,0861,086942
       Property Plant Equipment 
652
724
724
1,188
1,409
1,566
2,686
5,979
9,013
10,379
10,487
10,583
10,503
10,234
9,985
9,955
9,363
9,665
9,889
9,676
10,310
11,565
11,429
13,777
14,332
15,325
15,007
15,114
15,642
15,199
15,828
16,553
16,311
15,975
16,416
19,916
19,739
20,601
20,691
13,432
12,827
13,708
7,516
7,460
7,657
8,251
7,320
6,682
6,345
6,387
6,738
4,358
3,885
3,301
3,357
3,096
3,276
3,558
3,084
2,512
2,452
2,223
2,146
2,147
1,964
1,611
1,537
1,351
1,250
829
705
797
529
344
307
256
231
236
224
204
184
139
154
101
94
75
71
65
510
388
460
617
319
215
196
179
159
140
225
192
198
156
125
216
248
265
255
317
317255265248216125156198192225140159179196215319617460388510657175941011541391842042242362312563073445297977058291,2501,3511,5371,6111,9642,1472,1462,2232,4522,5123,0843,5583,2763,0963,3573,3013,8854,3586,7386,3876,3456,6827,3208,2517,6577,4607,51613,70812,82713,43220,69120,60119,73919,91616,41615,97516,31116,55315,82815,19915,64215,11415,00715,32514,33213,77711,42911,56510,3109,6769,8899,6659,3639,9559,98510,23410,50310,58310,48710,3799,0135,9792,6861,5661,4091,188724724652
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
119,169
120,058
125,283
127,319
10,748
10,870
11,063
11,228
10,492
11,395
11,336
10,107
10,083
9,511
10,060
10,517
10,246
9,708
8,790
9,772
9,614
10,204
10,424
9,569
9,313
9,588
9,103
9,234
9,466
9,215
9,335
9,699
9,892
9,888
9,833
9,067
8,687
7,700
8,030
8,043
7,836
8,161
8,004
8,026
7,553
7,664
8,191
8,486
8,613
8,844
8,383
8,330
8,210
8,053
8,177
7,849
8,050
7,882
8,054
8,406
8,815
8,433
8,533
8,326
8,130
7,977
7,487
7,034
0
0
0
0
0
000007,0347,4877,9778,1308,3268,5338,4338,8158,4068,0547,8828,0507,8498,1778,0538,2108,3308,3838,8448,6138,4868,1917,6647,5538,0268,0048,1617,8368,0438,0307,7008,6879,0679,8339,8889,8929,6999,3359,2159,4669,2349,1039,5889,3139,56910,42410,2049,6149,7728,7909,70810,24610,51710,0609,51110,08310,10711,33611,39510,49211,22811,06310,87010,748127,319125,283120,058119,16900000000000000000000000000000000000
       Intangible Assets 
0
0
0
419
493
613
721
715
0
0
0
821
814
799
824
2,007
0
0
0
15,234
15,159
17,609
17,022
72,763
77,742
77,611
89,366
97,702
128,083
125,863
129,012
134,449
146,442
141,251
140,951
109,380
108,968
114,465
112,825
39,106
38,482
37,843
38,920
30,391
32,151
31,099
26,939
23,894
21,942
22,911
23,344
17,034
15,760
13,926
15,098
14,478
3,349
3,266
1,940
1,769
1,698
1,496
1,399
1,128
989
891
810
708
671
449
391
352
292
284
264
237
226
201
183
70
137
94
95
90
104
93
86
62
55
50
44
40
35
32
28
59
541
541
642
625
612
573
537
0
0
0
0
0
000005375736126256425415415928323540445055628693104909594137701832012262372642842923523914496717088108919891,1281,3991,4961,6981,7691,9403,2663,34914,47815,09813,92615,76017,03423,34422,91121,94223,89426,93931,09932,15130,39138,92037,84338,48239,106112,825114,465108,968109,380140,951141,251146,442134,449129,012125,863128,08397,70289,36677,61177,74272,76317,02217,60915,15915,2340002,007824799814821000715721613493419000
       Long-term Assets Other 
290
362
362
0
0
0
0
0
729
814
749
0
0
0
0
433
4,969
1,966
13,744
0
0
0
0
665
853
942
858
1,019
1,645
6,989
8,647
5,644
6,377
5,767
5,715
4,355
4,149
4,353
5,203
58,482
1,262
1,087
9,011
15,440
9,043
2,018
1,861
5,959
7,754
7,327
8,277
5,611
5,289
4,863
5,375
5,211
1,821
1,041
1,623
1,636
1,737
1,714
1,691
1,623
1,594
1,624
1,661
1,590
1,497
1,505
1,278
1,382
1,202
1,188
736
775
1,089
1,086
1,350
1,089
1,134
1,144
828
531
539
373
422
418
363
367
8,249
364
358
313
325
338
325
410
449
335
460
436
300
322
326
325
320
332
3323203253263223004364603354494103253383253133583648,2493673634184223735395318281,1441,1341,0891,3501,0861,0897757361,1881,2021,3821,2781,5051,4971,5901,6611,6241,5941,6231,6911,7141,7371,6361,6231,0411,8215,2115,3754,8635,2895,6118,2777,3277,7545,9591,8612,0189,04315,4409,0111,0871,26258,4825,2034,3534,1494,3555,7155,7676,3775,6448,6476,9891,6451,019858942853665000013,7441,9664,969433000074981472900000362362290
> Total Liabilities 
942
869
1,303
1,118
704
817
1,769
2,535
3,313
4,274
4,358
4,440
5,594
5,501
5,180
7,722
22,317
14,329
22,507
23,489
24,404
26,671
27,149
124,472
87,674
87,608
108,122
107,733
143,752
154,233
162,116
161,520
191,559
140,269
133,462
251,476
216,964
217,751
217,173
44,612
38,281
32,975
32,972
34,772
39,466
37,730
31,700
86,867
111,181
114,071
111,601
77,036
68,802
63,007
66,069
64,135
92,520
94,520
78,831
79,915
82,730
67,190
65,788
74,360
63,355
45,121
32,373
42,132
45,221
43,891
48,113
32,951
44,893
47,839
36,077
29,883
27,749
28,016
28,457
25,447
22,729
20,015
24,493
24,978
24,899
22,124
21,052
23,104
25,944
23,779
23,695
22,444
17,954
16,738
17,123
24,066
22,840
23,005
22,116
27,116
23,185
17,531
17,188
20,250
20,074
17,404
16,208
18,820
18,82016,20817,40420,07420,25017,18817,53123,18527,11622,11623,00522,84024,06617,12316,73817,95422,44423,69523,77925,94423,10421,05222,12424,89924,97824,49320,01522,72925,44728,45728,01627,74929,88336,07747,83944,89332,95148,11343,89145,22142,13232,37345,12163,35574,36065,78867,19082,73079,91578,83194,52092,52064,13566,06963,00768,80277,036111,601114,071111,18186,86731,70037,73039,46634,77232,97232,97538,28144,612217,173217,751216,964251,476133,462140,269191,559161,520162,116154,233143,752107,733108,12287,60887,674124,47227,14926,67124,40423,48922,50714,32922,3177,7225,1805,5015,5944,4404,3584,2743,3132,5351,7698177041,1181,303869942
   > Total Current Liabilities 
942
869
1,303
1,118
634
817
1,769
2,275
3,048
1,967
2,111
1,744
2,905
2,800
2,517
4,551
3,685
4,029
14,356
16,883
17,887
18,629
19,491
83,993
32,645
33,074
48,305
47,380
56,112
57,884
62,639
60,114
60,849
75,471
75,560
62,201
57,981
62,448
63,512
16,310
19,161
17,612
18,658
22,255
26,120
24,046
17,611
22,170
26,038
27,058
23,071
19,268
14,836
14,840
13,371
13,487
16,668
19,042
15,583
17,885
16,838
15,846
14,360
15,705
13,701
23,374
8,599
7,242
5,763
5,668
7,364
7,574
6,317
5,579
18,601
6,425
5,316
5,462
5,519
4,204
3,386
4,030
5,596
5,769
7,308
5,616
5,372
5,596
5,623
7,022
5,454
5,659
3,191
2,531
1,797
5,014
4,946
4,547
4,777
7,766
5,666
6,407
5,968
7,044
6,434
4,077
4,228
4,540
4,5404,2284,0776,4347,0445,9686,4075,6667,7664,7774,5474,9465,0141,7972,5313,1915,6595,4547,0225,6235,5965,3725,6167,3085,7695,5964,0303,3864,2045,5195,4625,3166,42518,6015,5796,3177,5747,3645,6685,7637,2428,59923,37413,70115,70514,36015,84616,83817,88515,58319,04216,66813,48713,37114,84014,83619,26823,07127,05826,03822,17017,61124,04626,12022,25518,65817,61219,16116,31063,51262,44857,98162,20175,56075,47160,84960,11462,63957,88456,11247,38048,30533,07432,64583,99319,49118,62917,88716,88314,3564,0293,6854,5512,5172,8002,9051,7442,1111,9673,0482,2751,7698176341,1181,303869942
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
18,837
30,168
40,939
34,010
23,626
20,005
26,427
21,350
35,986
38,682
29,348
2,109
2,237
3,569
2,913
7,352
7,601
7,936
10,093
802
24,191
27,885
790
764
776
760
719
726
725
783
775
764
451
56
49
477
518
562
0
0
0
0
1,934
2,770
3,029
0
42
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
624
635
0
648
216
119
125
135
129
106
135
130
143
106
73
114
134
0
0
0
00013411473106143130135106129135125119216648063562400000000000000000000000000004203,0292,7701,9340000562518477495645176477578372572671976077676479027,88524,19180210,0937,9367,6017,3522,9133,5692,2372,10929,34838,68235,98621,35026,42720,00523,62634,01040,93930,16818,8370000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
624
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000006240000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
942
869
1,303
1,118
634
817
1,769
2,275
3,048
1,967
2,111
524
0
2,800
2,517
3,909
3,490
3,936
12,025
14,717
16,249
16,515
16,947
27,032
28,198
28,120
40,440
40,919
42,828
39,878
43,202
41,793
50,676
44,132
42,675
57,958
53,701
45,962
51,329
7,019
10,455
9,876
11,545
16,084
20,530
20,170
15,286
10,256
14,498
14,365
10,460
8,152
8,691
9,710
8,747
6,388
11,163
0
6,849
8,062
8,229
7,291
5,841
6,671
5,990
8,876
6,163
4,802
3,337
3,295
2,770
3,153
2,873
2,258
2,646
2,488
1,065
1,642
3,029
2,044
911
918
700
1,222
1,412
2,146
1,573
1,282
964
1,197
2,908
1,087
679
436
308
1,187
1,046
607
672
934
1,022
938
720
2,038
4,130
3,572
3,300
1,866
1,8663,3003,5724,1302,0387209381,0229346726071,0461,1873084366791,0872,9081,1979641,2821,5732,1461,4121,2227009189112,0443,0291,6421,0652,4882,6462,2582,8733,1532,7703,2953,3374,8026,1638,8765,9906,6715,8417,2918,2298,0626,849011,1636,3888,7479,7108,6918,15210,46014,36514,49810,25615,28620,17020,53016,08411,5459,87610,4557,01951,32945,96253,70157,95842,67544,13250,67641,79343,20239,87842,82840,91940,44028,12028,19827,03216,94716,51516,24914,71712,0253,9363,4903,9092,5172,80005242,1111,9673,0482,2751,7698176341,1181,303869942
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
1,220
2,905
-18,837
-30,168
-40,296
-33,814
-23,533
-17,674
-24,261
-19,712
-33,872
-36,138
27,613
2,338
2,717
4,296
3,549
5,932
10,405
11,501
8,228
9,372
7,147
5,001
3,453
3,516
10,356
5,724
3,002
2,347
1,937
923
23
0
0
0
4,234
48
52
56
3,824
59
56
58
3,054
0
13,346
3,279
4,212
3,186
3,458
3,381
3,799
3,721
2,656
2,436
2,440
2,426
2,373
4,594
4,151
3,205
3,071
15,705
3,693
3,997
3,571
2,037
1,734
2,043
2,650
4,417
4,061
2,596
566
1,460
2,571
2,324
3,454
877
1,485
1,074
1,380
745
1,104
1,292
1,326
1,522
1,887
1,919
1,829
1,691
1,943
153
3,932
0
0
003,9321531,9431,6911,8291,9191,8871,5221,3261,2921,1047451,3801,0741,4858773,4542,3242,5711,4605662,5964,0614,4172,6502,0431,7342,0373,5713,9973,69315,7053,0713,2054,1514,5942,3732,4262,4402,4362,6563,7213,7993,3813,4583,1864,2123,27913,34603,0545856593,8245652484,234000239231,9372,3473,0025,72410,3563,5163,4535,0017,1479,3728,22811,50110,4055,9323,5494,2962,7172,33827,613-36,138-33,872-19,712-24,261-17,674-23,533-33,814-40,296-30,168-18,8372,9051,22000000000000
   > Long-term Liabilities 
0
0
0
0
70
0
0
260
265
2,306
2,247
2,696
2,688
2,701
2,662
3,170
18,631
10,300
8,151
6,606
6,517
8,041
7,658
40,478
55,030
54,534
59,817
60,353
87,640
96,349
99,477
101,406
130,710
64,798
57,902
189,275
158,983
155,303
153,661
28,302
19,119
15,363
14,315
12,517
13,346
13,684
14,089
64,697
85,143
87,013
88,530
57,768
53,966
48,167
52,698
50,648
75,852
75,478
63,248
62,030
65,892
51,344
51,428
58,655
49,654
21,747
23,774
34,890
39,458
38,223
40,749
25,377
38,576
42,260
17,476
23,458
22,433
22,554
22,938
21,243
19,343
15,985
18,897
19,209
17,591
16,508
15,680
17,508
20,321
16,757
18,241
16,785
14,763
14,207
15,326
19,052
17,894
18,458
17,339
19,350
17,519
11,124
11,220
13,206
13,640
13,327
11,980
14,280
14,28011,98013,32713,64013,20611,22011,12417,51919,35017,33918,45817,89419,05215,32614,20714,76316,78518,24116,75720,32117,50815,68016,50817,59119,20918,89715,98519,34321,24322,93822,55422,43323,45817,47642,26038,57625,37740,74938,22339,45834,89023,77421,74749,65458,65551,42851,34465,89262,03063,24875,47875,85250,64852,69848,16753,96657,76888,53087,01385,14364,69714,08913,68413,34612,51714,31515,36319,11928,302153,661155,303158,983189,27557,90264,798130,710101,40699,47796,34987,64060,35359,81754,53455,03040,4787,6588,0416,5176,6068,15110,30018,6313,1702,6622,7012,6882,6962,2472,30626526000700000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
718
570
408
255
144
103
76
49
15
12
65
31
22
16
16
65
76
85
70
0
0708576651616223165121549761031442554085707180000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,343
15,985
18,897
19,209
17,591
16,508
15,680
17,508
19,603
16,187
17,819
16,530
14,619
14,104
15,250
19,003
17,879
18,446
17,274
19,319
17,497
11,108
11,204
0
0
13,242
0
0
0013,2420011,20411,10817,49719,31917,27418,44617,87919,00315,25014,10414,61916,53017,81916,18719,60317,50815,68016,50817,59119,20918,89715,98519,34300000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
26,596
34,405
34,313
33,054
33,322
31,788
30,462
28,661
27,966
27,270
26,285
37,558
45,549
52,506
58,618
56,463
39,079
46,183
58,569
60,904
57,724
94,558
88,152
70,085
76,042
79,246
97,387
97,258
94,047
95,092
96,960
100,065
99,790
111,148
108,988
109,531
138,412
143,517
136,875
178,879
100,995
102,291
100,777
88,591
77,988
57,819
40,858
21,475
7,850
3,369
-7,985
9,226
3,170
22,509
14,791
12,439
-23,527
-15,292
-4,067
-4,546
-8,677
-1,822
-7,520
-6,695
-3,961
7,790
17,598
17,064
16,427
10,249
7,404
14,484
20,381
9,407
12,824
21,615
16,297
9,051
3,282
6,212
5,352
4,491
-1,955
-2,783
11,542
9,510
7,410
1,907
-3,560
-3,028
-2,193
-2,463
1,687
931
15,148
13,211
64,174
61,347
59,926
52,986
53,159
54,294
49,418
35,776
31,208
29,079
26,278
18,196
18,19626,27829,07931,20835,77649,41854,29453,15952,98659,92661,34764,17413,21115,1489311,687-2,463-2,193-3,028-3,5601,9077,4109,51011,542-2,783-1,9554,4915,3526,2123,2829,05116,29721,61512,8249,40720,38114,4847,40410,24916,42717,06417,5987,790-3,961-6,695-7,520-1,822-8,677-4,546-4,067-15,292-23,52712,43914,79122,5093,1709,226-7,9853,3697,85021,47540,85857,81977,98888,591100,777102,291100,995178,879136,875143,517138,412109,531108,988111,14899,790100,06596,96095,09294,04797,25897,38779,24676,04270,08588,15294,55857,72460,90458,56946,18339,07956,46358,61852,50645,54937,55826,28527,27027,96628,66130,46231,78833,32233,05434,31334,40526,596
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
41,671
44,406
52,499
53,105
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
110,295
117,224
117,262
0
121,289
139,849
140,258
60,149
81,424
81,975
82,138
0
109,287
0
0
122,791
122,791
124,160
129,185
134,101
138,704
138,704
148,502
150,544
157,545
167,517
186,022
204,596
204,596
204,640
205,139
213,980
216,534
218,283
222,335
222,335
222,335
222,335
222,335
222,335
222,335
223,140
224,531
224,528
226,413
226,724
235,008
235,008
293,781
293,347
293,347
293,410
293,410
293,410
293,410
293,410
293,410
293,410
293,410
0
0293,410293,410293,410293,410293,410293,410293,410293,410293,347293,347293,781235,008235,008226,724226,413224,528224,531223,140222,335222,335222,335222,335222,335222,335222,335218,283216,534213,980205,139204,640204,596204,596186,022167,517157,545150,544148,502138,704138,704134,101129,185124,160122,791122,79100109,287082,13881,97581,42460,149140,258139,849121,2890117,262117,224110,29500000000000000000000000000000000053,10552,49944,40641,67100000000000
   Retained Earnings 
1,377
1,376
1,375
1,328
1,338
817
262
-1,300
-2,585
-4,070
-5,243
-4,112
-814
-2,117
-634
-3,310
-11,966
-7,478
-10,353
-11,987
-15,508
-20,200
-23,222
-28,498
-33,859
-40,289
-46,967
-56,302
-57,627
-55,680
-60,440
-65,525
-64,996
-50,791
-57,605
-43,224
-46,158
-47,699
-54,204
-10,114
-15,805
-20,622
-29,389
-42,997
-53,832
-74,442
-88,321
-102,814
-115,202
-128,282
-139,570
-127,538
-133,418
-137,868
-148,015
-150,756
-170,624
-181,193
-180,115
-188,969
-200,420
-195,880
-202,434
-213,086
-211,200
-201,870
-198,028
-203,925
-209,240
-215,375
-227,811
-222,322
-233,359
-246,197
-261,487
-271,621
-276,723
-284,527
-290,982
-298,059
-301,749
-304,105
-313,736
-314,161
-299,737
-302,134
-304,237
-309,781
-315,427
-315,977
-316,844
-316,891
-314,724
-319,592
-321,363
-322,659
-323,222
-326,229
-327,708
-334,619
-334,510
-333,450
-338,664
-352,084
-356,501
-358,936
-357,003
-369,831
-369,831-357,003-358,936-356,501-352,084-338,664-333,450-334,510-334,619-327,708-326,229-323,222-322,659-321,363-319,592-314,724-316,891-316,844-315,977-315,427-309,781-304,237-302,134-299,737-314,161-313,736-304,105-301,749-298,059-290,982-284,527-276,723-271,621-261,487-246,197-233,359-222,322-227,811-215,375-209,240-203,925-198,028-201,870-211,200-213,086-202,434-195,880-200,420-188,969-180,115-181,193-170,624-150,756-148,015-137,868-133,418-127,538-139,570-128,282-115,202-102,814-88,321-74,442-53,832-42,997-29,389-20,622-15,805-10,114-54,204-47,699-46,158-43,224-57,605-50,791-64,996-65,525-60,440-55,680-57,627-56,302-46,967-40,289-33,859-28,498-23,222-20,200-15,508-11,987-10,353-7,478-11,966-3,310-634-2,117-814-4,112-5,243-4,070-2,585-1,3002628171,3381,3281,3751,3761,377
   Accumulated Other Comprehensive Income 
-290
-290
-290
-419
-423
-408
-393
-585
-596
-611
-613
-1,016
-1,015
-1,016
-1,017
-1,798
-1,799
-1,782
-1,710
-2,386
-2,381
-2,504
-2,393
1,031
5,304
5,569
5,611
8,892
8,263
9,009
7,531
8,143
5,511
4,669
887
11,937
11,372
17,370
16,695
14,301
9,606
15,331
21,774
21,716
21,741
22,247
19,063
14,054
12,757
12,819
12,715
12,719
12,400
10,899
12,919
12,768
-338
-864
43
212
-43
9
-88
-292
-52
-193
357
781
804
687
300
-377
1,398
904
883
1,132
663
893
831
1,701
1,568
909
509
271
49
21
24
11
95
-15
0
94
304
95
-388
-1,045
-498
-624
-585
-678
-641
-599
-704
-967
-1,135
0
0
0
000-1,135-967-704-599-641-678-585-624-498-1,045-38895304940-1595112421492715099091,5681,7018318936631,1328839041,398-377300687804781357-193-52-292-889-4321243-864-33812,76812,91910,89912,40012,71912,71512,81912,75714,05419,06322,24721,74121,71621,77415,3319,60614,30116,69517,37011,37211,9378874,6695,5118,1437,5319,0098,2638,8925,6115,5695,3041,031-2,393-2,504-2,381-2,386-1,710-1,782-1,799-1,798-1,017-1,016-1,015-1,016-613-611-596-585-393-408-423-419-290-290-290
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
25,509
33,319
33,227
32,145
32,406
31,380
30,593
30,545
31,147
31,950
32,141
1,016
2,972
3,142
7,164
61,571
52,844
55,443
70,632
75,276
75,613
117,262
113,767
97,552
104,597
113,967
138,744
144,668
143,411
141,763
149,869
157,447
159,275
157,269
165,706
140,818
173,198
173,846
174,384
174,692
107,194
107,582
108,392
109,872
110,078
110,014
110,116
110,235
0
1,608
1,608
124,045
2,899
9,629
9,629
90,278
66,011
84,790
93,867
184,211
82,499
194,049
195,002
83,892
84,500
85,693
86,084
86,107
86,159
86,233
86,413
86,639
94,797
87,183
87,406
87,508
87,761
88,045
88,294
88,590
88,999
89,404
88,937
88,772
88,895
89,288
89,288
89,342
89,437
89,824
-2,193
89,806
89,694
93,704
101,891
101,907
94,113
94,853
94,872
94,873
94,900
94,933
95,376
95,417
95,434
94,605
89,871
0
089,87194,60595,43495,41795,37694,93394,90094,87394,87294,85394,113101,907101,89193,70489,69489,806-2,19389,82489,43789,34289,28889,28888,89588,77288,93789,40488,99988,59088,29488,04587,76187,50887,40687,18394,79786,63986,41386,23386,15986,10786,08485,69384,50083,892195,002194,04982,499184,21193,86784,79066,01190,2789,6299,6292,899124,0451,6081,6080110,235110,116110,014110,078109,872108,392107,582107,194174,692174,384173,846173,198140,818165,706157,269159,275157,447149,869141,763143,411144,668138,744113,967104,59797,552113,767117,26275,61375,27670,63255,44352,84461,5717,1643,1422,9721,01632,14131,95031,14730,54530,59331,38032,40632,14533,22733,31925,509



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue4,498
Cost of Revenue-222
Gross Profit4,2764,276
 
Operating Income (+$)
Gross Profit4,276
Operating Expense-22,506
Operating Income-18,008-18,230
 
Operating Expense (+$)
Research Development13,560
Selling General Administrative8,724
Selling And Marketing Expenses-
Operating Expense22,50622,284
 
Net Interest Income (+$)
Interest Income1,126
Interest Expense--
Other Finance Cost-0
Net Interest Income1,126
 
Pretax Income (+$)
Operating Income-18,008
Net Interest Income1,126
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-16,552-18,338
EBIT - interestExpense = 0
-16,552
-16,552
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--16,552
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-16,552
Tax Provision-0
Net Income From Continuing Ops-16,552-16,552
Net Income-16,552
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net330-1,126
 

Technical Analysis of Zentaris
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zentaris. The general trend of Zentaris is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zentaris's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Aeterna Zentaris Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 2.68 < 2.85 < 3.01.

The bearish price targets are: 2.46 > 2.29 > 2.28.

Tweet this
Aeterna Zentaris Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Aeterna Zentaris Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Aeterna Zentaris Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Aeterna Zentaris Inc. The current macd is 0.00125961.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Zentaris price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Zentaris. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Zentaris price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Aeterna Zentaris Inc Daily Moving Average Convergence/Divergence (MACD) ChartAeterna Zentaris Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Aeterna Zentaris Inc. The current adx is 32.73.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Zentaris shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Aeterna Zentaris Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Aeterna Zentaris Inc. The current sar is 3.13193672.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Aeterna Zentaris Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Aeterna Zentaris Inc. The current rsi is 44.55. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Aeterna Zentaris Inc Daily Relative Strength Index (RSI) ChartAeterna Zentaris Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Aeterna Zentaris Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Zentaris price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Aeterna Zentaris Inc Daily Stochastic Oscillator ChartAeterna Zentaris Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Aeterna Zentaris Inc. The current cci is -133.33333333.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Aeterna Zentaris Inc Daily Commodity Channel Index (CCI) ChartAeterna Zentaris Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Aeterna Zentaris Inc. The current cmo is -21.1249897.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Aeterna Zentaris Inc Daily Chande Momentum Oscillator (CMO) ChartAeterna Zentaris Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Aeterna Zentaris Inc. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Aeterna Zentaris Inc Daily Williams %R ChartAeterna Zentaris Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Aeterna Zentaris Inc.

Aeterna Zentaris Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Aeterna Zentaris Inc. The current atr is 0.08271012.

Aeterna Zentaris Inc Daily Average True Range (ATR) ChartAeterna Zentaris Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Aeterna Zentaris Inc. The current obv is -115,796.

Aeterna Zentaris Inc Daily On-Balance Volume (OBV) ChartAeterna Zentaris Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Aeterna Zentaris Inc. The current mfi is 21.84.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Aeterna Zentaris Inc Daily Money Flow Index (MFI) ChartAeterna Zentaris Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Aeterna Zentaris Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-14MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-20MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Aeterna Zentaris Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Aeterna Zentaris Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.550
Ma 20Greater thanMa 502.782
Ma 50Greater thanMa 1002.653
Ma 100Greater thanMa 2002.667
OpenGreater thanClose2.680
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zentaris with someone you think should read this too:
  • Are you bullish or bearish on Zentaris? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zentaris? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Aeterna Zentaris Inc

I send you an email if I find something interesting about Aeterna Zentaris Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Aeterna Zentaris Inc.

Receive notifications about Aeterna Zentaris Inc in your mailbox!